Title	Publication Date	Language	Citations
Classical and new prognostic factors in chronic lymphocytic leukemia: Where to now?	2002/01/01		27
All trans retinoic acid in combination with intermediate-dose cytarabine and idarubicin in patients with relapsed or refractory non promyelocytic acute myeloid leukemia: a phase II randomized trial	2002/01/01		27
Thalidomide in patients with advanced multiple myeloma	2000/01/01		26
Specific dose-response effects of TGF-β1 on developmentally distinct hematopoietic stem/progenitor cells from human umbilical cord blood	2000/01/01		25
Autologous peripheral blood progenitor cell transplantation with <2×106 CD34+/kg: an analysis of variables concerning mobilisation and engraftment	2000/01/01		25
Stem cell defect in aplastic anemia: reduced long term culture-initiating cells (LTC-IC) in CD34+ cells isolated from aplastic anemia patient bone marrow	2002/01/01		25
Cytokine release by activated T-cells in large granular lymphocytic leukemia associated with autoimmune disorders	2002/01/01		24
Management of disease-related anemia in patients with multiple myeloma or chronic lymphocytic leukemia: epoetin treatment recommendations	2002/01/01		23
Phenotypic and functional analysis of the HLA-class I-specific inhibitory receptors of natural killer cells isolated from peripheral blood of patients undergoing bone marrow transplantation from matched unrelated donors	2000/01/01		22
A novel treatment approach for low grade lymphoproliferative disorders using PKC412 (CGP41251), an inhibitor of protein kinase C	2002/01/01		22
Plasma thrombopoietin levels in patients with chronic renal failure	2002/01/01		21
Acute lymphoblastic leukemia in the elderly	2002/01/01		21
Inhibition of telomerase activity with hTERT antisense increases the effect of CDDP-induced apoptosis in myeloid leukemia	2002/01/01		20
Prevention of postsplenectomy sepsis: how much do patients know?	2000/01/01		20
Primary orbital lymphoma	2002/01/01		19
Hodgkin's disease primarily involving the oropharynx: case report and review of the literature	2002/01/01		18
HLA class I-minor histocompatibility antigen tetramers select cytotoxic T cells with high avidity to the natural ligand	2000/01/01		18
Sustained complete remission of chronic refractory immune thrombocytopenic purpura (ITP) of 10 years duration after only two infusions of rituximab	2002/01/01		17
Dose-finding study of valspodar (PSC 833) with daunorubicin and cytarabine to reverse multidrug resistance in elderly patients with previously untreated acute myeloid leukemia	2000/01/01		17
Interleukin-10 inhibits in vitro hematopoietic suppression and production of interferon-gamma and tumor necrosis factor-alpha by peripheral blood mononuclear cells from patients with aplastic anemia	2002/01/01		15
Recurrent molecular deletion of the 12p13 region, centromeric to ETV6/TEL, in T-cell prolymphocytic leukemia	2000/01/01		15
Normal and chronic phase CML hematopoietic cells repopulate NOD/SCID bone marrow with different kinetics and cell lineage representation	2000/01/01		15
Polymorphonuclear leukocytes released from the bone marrow by granulocyte colony-stimulating factor: intravascular behavior	2000/01/01		14
Role of early anthracycline dose-intensity according to expression of Philadelphia chromosome/BCR–ABL rearrangements in B-precursor adult acute lymphoblastic leukemia	2000/01/01		14
Molecular characterization of four novel mutations causing factor VII deficiency	2000/01/01		13
Molecular basis of haemoglobinopathies and G6PD deficiency in the Comorian population	2000/01/01		13
Functional G-CSF pathways in t(8;21) leukemic cells allow for differentiation induction and degradation of AML1-ETO	2000/01/01		13
Contact-mediated inhibition of human haematopoietic progenitor cell proliferation may be conferred by stem cell antigen, CD34	2000/01/01		13
Increased erythropoietin level induced by hydroxyurea treatment of sickle cell patients	2000/01/01		13
Gene expression in CD34+ cells from normal bone marrow and leukemic origins	2000/01/01		12